LONDON, March 21, 2014 /PRNewswire/ --
The trading session on Thursday, March
20, 2014 ended on a higher note as the Dow Jones Industrial
Average finished at 16,331.05, up 0.67% and the NASDAQ Composite
closed at 4,319.29, up 0.27%. The S&P 500 finished the session
0.60% higher at 1,872.01. The gains were broad based with 9 of 10
sectors ended the session in positive. Investor-Edge looks at some
of the equities which traded the most shares during the session.
These include FullStarbucks Corp. (NASDAQ: SBUX), Gerdau S.A.
(NYSE: GGB), Mast Therapeutics Inc. (NYSE MKT: MSTX) and Cia de
Saneamento Basico do Estado de Sao
Paulo (NYSE: SBS). Free technical research on SBUX, GGB,
MSTX and SBS can be downloaded upon signing up at:
http://www.investor-edge.com/397-register
On Thursday, Starbucks Corp.'s shares recorded heavy trading as a
total of 6.91 million shares changed hands, as compared with the
three-month average volume of 6.27 million shares. The stock traded
at an intraday trading range of $75.60 and $77.13,
before closing the day at $76.96, up
1.38%. Starbucks Corp.'s shares have gained 3.74% in the past three
trading sessions, 4.63% in the last one month, while the same has
declined 1.83% on YTD basis. The S&P 500 Consumer Discretionary
Sector Index mapped a gain of 1.73% in the last one month, while
the S&P 500 went up by 1.75% during the same period. The stock
is trading above its 50-day and 200-day moving averages of
$73.67 and $74.06, respectively. The stock is trading at a
Relative Strength Index (RSI) of 60.94. Sign up today to read free
research on SBUX at:
http://www.investor-edge.com/397-SBUX-.pdf
Shares in Gerdau S.A. recorded heavy trading as a total of 6.26
million shares changed hands, against a three-month average volume
of 4.96 million shares. On Thursday, the stock finished the day at
$6.10, up 0.16% and at an intraday
range of $5.95 and $6.18. Gerdau S.A.'s shares have advanced 1.67%
in the past three trading sessions, while the same has fallen by
5.72% in the last one month and 22.19% on YTD basis. The S&P
500 Materials Sector Index mapped a gain of 4.89% in the last three
months, while the S&P 500 went up by 2.95% during the same
period. The stock is trading below its 50-day and 200-day moving
averages of $6.70 and $7.03, respectively. The company's shares are
trading at an RSI of 41.47. Sign up today to read free research on
GGB at:
http://www.investor-edge.com/397-GGB-.pdf
Mast Therapeutics Inc.'s shares registered heavy trading as a total
of 21.52 million shares changed hands on Thursday, as compared with
the three-month average volume of 4.04 million shares. The stock
closed the day at $0.83, up 12.12%
and at an intraday range of $0.72 and
$0.93. The company's shares have
surged 8.95% in the previous three trading sessions, 99.52% in the
last three months and 79.08% on YTD basis. The S&P 500 Health
Care Sector Index went up by 7.91% in the last three months, while
the S&P 500 gained 2.95% during the same period. The stock is
trading above its 50-day and 200-day moving averages of
$0.81 and $0.55, respectively. The company's shares have an
RSI of 39.47. Sign up today to read free research on MSTX at:
http://www.investor-edge.com/397-MSTX-.pdf
Shares in Cia de Saneamento Basico do Estado de Sao Paulo recorded heavy trading as a total of
7.16 million shares were exchanged, against a three-month average
volume of 2.33 million shares. On Thursday, the stock finished the
day at $8.39, down 6.57% and with an
intraday fluctuation between $8.38 and
$8.87. Cia de Saneamento Basico do Estado de Sao Paulo's shares have lost 3.01% in the past
three trading sessions, and 26.01% on YTD basis. The S&P 500
Utilities Sector Index advanced 6.11% in the last three months,
while the S&P 500 went up by 2.95% during the same period. The
stock is trading below its 50-day and 200-day moving averages of
$9.41 and $10.06, respectively. The company's shares have
an RSI of 46.40. Sign up today to read free research on SBS at:
http://www.investor-edge.com/397-SBS-.pdf
===============
EDITOR'S NOTES:
===============
1. This is not company news. We are an independent source and our
views do not reflect the companies mentioned.
2. Information in this release is fact checked and produced on a
best efforts basis and reviewed by Nidhi Vatsal, a CFA
charterholder. However, we are only human and are prone to make
mistakes. If you notice any errors or omissions, please notify us
below.
3. This information is submitted as a net-positive to companies
mentioned, to increase awareness for mentioned companies to our
subscriber base and the investing public.
4. If you wish to have your company covered in more detail by our
team, or wish to learn more about our services, please contact us
at pubco [at] http://www.investor-edge.com.
5. For any urgent concerns or inquiries, please contact us at
compliance [at] http://www.investor-edge.com.
6. Are you a public company? Would you like to see similar coverage
on your company? Send us a full investors' package to research [at]
http://www.investor-edge.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis.
This document, article or report is prepared and authored by
Investor-edge. An outsourced research services provider represented
by Nidhi Vatsal, CFA, has only reviewed the information provided by
Investor-edge in this article or report according to the Procedures
outlined by Investor-edge. Investor-edge is not entitled to veto or
interfere in the application of such procedures by the outsourced
provider to the articles, documents or reports, as the case may
be.
NOT FINANCIAL ADVICE
Investor-edge makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or
otherwise), of the information provided in this document. This
information is not to be construed as personal financial advice.
Readers are encouraged to consult their personal financial advisor
before making any decisions to buy, sell or hold any securities
mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-edge is not responsible for any error which may be
occasioned at the time of printing of this document or any error,
mistake or shortcoming. No liability is accepted by Investor-edge
whatsoever for any direct, indirect or consequential loss arising
from the use of this document. Investor-edge expressly disclaims
any fiduciary responsibility or liability for any consequences,
financial or otherwise arising from any reliance placed on the
information in this document. Investor-edge does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the
information. The included information is subject to change without
notice.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE Investor-Edge